 FARMINGDALE, N.Y., Nov. 05, 2020 GLOBE NEWSWIRE -- Misonix, Inc. Nasdaq: MSON Misonix or the Company, a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today reported unaudited financial results for the fiscal 2021 first quarter ended September 30, 2020 as summarized below: 